domingo, 19 de junio de 2016

NIAID Funding News, June 15, 2016


June 15, 2016 NIAID Funding News

Feature Articles 

The Benefits of Being a Peer Reviewer

It's been said that we learn by doing, and that certainly applies to the peer review of grant applications.

Opportunities and Resources

Develop Novel Immunogens for Vaccine Development

Consider applying to a new R01 funding opportunity announcement if you can propose to do the following: Use innovative, structure-based vaccine design approaches to develop novel vaccine immunogens against current and emerging infectious disease pathogens of clinical concern.

Strengthening HIV Prevention Through Epidemiology and Technology

A new funding opportunity announcement could be for you if you can propose innovative technology approaches to enroll large cohorts to study HIV transmission risk in U.S. populations at highest risk of HIV infection.

An Opportunity Renewed: Sustained Release of Antivirals for Treatment or Prevention of HIV

Are you interested in developing innovative strategies that may prevent and treat HIV? If so, we have just the opportunity for you!

Explore Immune Response Dynamics Through Cooperative Agreement FOA

Now's your chance to identify previously unappreciated key immune regulatory genes, signaling pathways, or mechanisms.

In The News

Know When NIH Will Fund Chimpanzee Research

Effective immediately, NIH will fund new or competing applications proposing chimpanzee research only if the research is noninvasive, as defined in the “Standards of Care for Chimpanzees Held in the Federally Supported Chimpanzee Sanctuary System” at 42 CFR part 9.

News Briefs

Advice Corner

What to Do After You Apply, Before Your Application's Peer Review

If you think your work is done once you submit your application, think again. Even after the viewing window closes, you can still improve your chances of success.

Reader Questions

New Funding Opportunities

See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to

No hay comentarios: